Covered recipient · General Payments record
DENNIS MCBROOM
Podiatric Medicine & Surgery Service Providers Podiatrist Foot & Ankle Surgery
General Payments · PY2018–2024
$4,735.16
- Reported across 92 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $703.87 | 14 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Stryker Corporation | $258.47 | 2 |
| ShockWave Medical, Inc | $140.40 | 1 |
| Solventum Corporation | $85.98 | 1 |
| Amgen Inc. | $64.32 | 2 |
| Smith & Nephew, Inc. | $39.23 | 1 |
| Integra LifeSciences Corporation | $30.83 | 1 |
| Paratek Pharmaceuticals, Inc. | $29.88 | 2 |
| ABBVIE INC. | $29.51 | 2 |
| Nevro Corp. | $15.33 | 1 |
| Advanced Oxygen Therapy Inc. | $9.92 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.54 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104993407 | CMS |
| ABBVIE INC. | $13.97 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104993409 | CMS |
| Advanced Oxygen Therapy Inc. | $9.92 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143010389 | CMS |
| Amgen Inc. | $29.64 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111647134 | CMS |
| Amgen Inc. | $34.68 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111647136 | CMS |
| Integra LifeSciences Corporation | $30.83 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140091598 | CMS |
| Nevro Corp. | $15.33 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130727626 | CMS |
| Paratek Pharmaceuticals, Inc. | $15.08 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113909790 | CMS |
| Paratek Pharmaceuticals, Inc. | $14.80 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113909792 | CMS |
| ShockWave Medical, Inc | $140.40 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152995187 | CMS |
| Smith+Nephew, Inc. | $39.23 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149481778 | CMS |
| Solventum Corporation | $85.98 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144080022 | CMS |
| Stryker Corporation | $97.19 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119910080 | CMS |
| Stryker Corporation | $161.28 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119910082 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.